In what is proving to be yet another example of how closely intertwined the burgeoning mHealth industry is with Apple’s most popular mobile products, the FDA has now formally given the green light to a company named Withings (a French start-up that designs, develops, and industrializes connected devices), which has pioneered an iOS blood pressure monitor.
The product is now shipping in the US.
According to the description made available in FDA’s formal clearance, “The Withings Blood Pressure Monitor… is a noninvasive blood pressure measurement [system] intended to measure the systolic and diastolic blood pressures and pulse rate of an adult individual, over age 18, at home by using a non-invasive technique in which an inflatable cuff is wrapped around the upper arm.”
First touted earlier this year at the Consumer Electronics Show, the mobile BP monitor ($129.99) pictured on the right requires three AAA batteries and is compatible with the iPhone, iPad, and iPod Touch. A free corresponding iOS app captures and provides blood pressure results approximately thirty seconds after the test is initiated. The BP readings are logged as well as timestamped for record-keeping purposes. The readouts can be subsequently emailed to a physician.
According to the folks at Withings, the app can be synced to health monitoring services like Microsoft HealthVault and Google Health.
With more than 25% of the world’s population affected by hypertension, Withings has combined advanced technology and sophisticated design to create a medical device that is visually attractive, accurate and easy to use at home, in a professional setting or on the go.
Cédric Hutchings, Withings co-founder says, “Apple has revolutionized the smartphone and tablet market with both its design and functionality. We have strived to extend this revolution into the field of health and fitness by integrating our products to work seamlessly with Apple iOS devices.”